Evidence map›Paper›PMID 32015100›Full record

ArticleMolecular and cellular biology2020

Interleukin-8 Dedifferentiates Primary Human Luminal Cells to Multipotent Stem Cells.

Huda H Al-Khalaf, Hazem Ghebeh, Salma M Wakil, Falah Al-Mohanna, Abdelilah Aboussekhra

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Huda H Al-KhalafDepartment of Molecular Oncology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Hazem GhebehStem Cell and Tissue Re-engineering Program, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Salma M WakilDepartment of Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Falah Al-MohannaDepartment of Comparative Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Abdelilah AboussekhraDepartment of Molecular Oncology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia aboussekhra@kfshrc.edu.sa.
King Faisal Specialist Hospital & Research Centre · SAKing Abdulaziz City for Science and Technology · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During aging, cellular plasticity and senescence play important roles in tissue regeneration and the pathogenesis of different diseases, including cancer. We have recently shown that senescent breast luminal cells can activate their adjacent stromal fibroblasts. In the present report, we present clear evidence that these senescence-related active fibroblasts can dedifferentiate proliferating primary human luminal cells to multipotent stem cells in an interleukin-8 (IL-8)-dependent manner. This was confirmed using recombinant IL-8, while the truncated protein was not active. This IL-8-related dedifferentiation of luminal cells was mediated through the STAT3-dependent downregulation of p16

Indexed as

BreastCell DedifferentiationCell Line, TumorCell MovementCellular SenescenceCyclin-Dependent Kinase Inhibitor p16Epithelial-Mesenchymal TransitionFemaleFibroblastsHumansInterleukin-6Interleukin-8MicroRNAsMultipotent Stem CellsSTAT3 Transcription FactorStromal CellsCyclin-Dependent Kinase Inhibitor p16Interleukin-6Interleukin-8MicroRNAsMIRN141 microRNA, humanSTAT3 protein, humanSTAT3 Transcription Factorcell differentiationIL-8STAT3stem cells

Identifiers

PMID32015100
PMCPMC7156216
OpenAlexW3004374734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.